| 2016-12 | Gene Expression Profile in Patients with Axial Spondyloarthritis: Meta-analysis of Publicly Accessible Microarray Datasets | 김태환 |
| 2014-07 | Gene expression profile predicting the response to anti-TNF treatment in patients with rheumatoid arthritis | 김태환 |
| 2011-02 | Genetic Studies of Ankylosing Spondylitis in Koreans Confirm Associations with ERAP1 and 2p15 Reported in White Patients | 김태환 |
| 2013-10 | Genetic Variants In OPG and ANKH Are Associated With Severity Ofankylosis In Ankylosing Spondylitis In a Korean Cohort | 김태환 |
| 2020-11 | Genome-wide association study in a Korean population identifies six novel susceptibility loci for rheumatoid arthritis | 김태환 |
| 2014-08 | Genome-Wide Copy Number Variation Analysis Identifies Deletion Variants Associated With Ankylosing Spondylitis | 김태환 |
| 2015-12 | High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation | 김태환 |
| 2015-03 | High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci | 김태환 |
| 2016-03 | High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry | 김태환 |
| 2013-10 | HLA-B27 homozygosity has no influence on radiographic damage in ankylosing spondylitis: Observation Study of Korean spondyloArthropathy Registry (OSKAR) data | 김태환 |
| 2015-11 | An HLA-C amino-acid variant in addition to HLA-B*27 confers risk for ankylosing spondylitis in the Korean population | 김태환 |
| 2013-06 | HYPERTENSION AND ITS INFLUENCE ON CARDIOVASCULAR RISK AND RA OUTCOMES | 김태환 |
| 2018-01 | Identification and characterization of human bone-derived cells | 김태환 |
| 2020-03 | Identification of highly potent and selective inhibitor, TIPTP, of the p22phox-Rubicon axis as a therapeutic agent for rheumatoid arthritis | 김태환 |
| 2014-01 | Identification of key regulators for the migration and invasion of rheumatoid synoviocytes through a systems approach | 김태환 |
| 2013-06 | Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci | 김태환 |
| 2016-01 | Identification of Ten Additional Susceptibility Loci for Ulcerative Colitis Through Immunochip Analysis in Koreans | 김태환 |
| 2018-06 | IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis | 김태환 |
| 2018-05 | Immunochip Meta-Analysis of Inflammatory Bowel Disease Identifies Three Novel Loci and Four Novel Associations in Previously Reported Loci | 김태환 |
| 2017-07 | Impact of early diagnosis on functional disability in rheumatoid arthritis | 김태환 |
| 2017-10 | Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis | 김태환 |
| 2013-06 | IMPACTS OF IMMEDIATE CHANGES IN DMARDS ON OUTCOMES IN RHEUMATOID ARTHRITIS WITH MODERATE-TO-SEVERE ACTIVITY | 김태환 |
| 2016-02 | Imputing Variants in HLA-DR Beta Genes Reveals That HLA-DRB1 Is Solely Associated with Rheumatoid Arthritis and Systemic Lupus Erythematosus | 김태환 |
| 2016-09 | Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study | 김태환 |
| 2011-10 | Incidence of Tuberculosis Among Korean Patients with Ankylosing Spondylitis Who Are Taking Tumor Necrosis Factor Blockers | 김태환 |
| 2011-06 | Infliximab으로 치료한 건선 관절염 환자의 지염 1예 | 김태환 |
| 2011-12 | Integrated Analysis of MicroRNA and mRNA Expression Profiles in Rheumatoid Arthritis Synovial Monocytes | 김태환 |
| 2018-09 | Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy | 김태환 |
| 2020-01 | Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial | 김태환 |
| 2012-06 | Korean Observational Study Network for Arthritis (KORONA): Establishment of a Prospective Multicenter Cohort for Rheumatoid Arthritis in South Korea | 김태환 |
